Ligand decorated biodegradable nanomedicine in the treatment of cancer
المؤلف | Ejaj, Ahmad |
المؤلف | Ali, Asgar |
المؤلف | Fatima, Munazza Tamkeen |
المؤلف | Nimisha |
المؤلف | Apurva |
المؤلف | Kumar, Arun |
المؤلف | Sumi, Mamta P. |
المؤلف | Sattar, Real Sumayya Abdul |
المؤلف | Mahajan, Bhawna |
المؤلف | Saluja, Sundeep Singh |
تاريخ الإتاحة | 2023-09-05T08:39:25Z |
تاريخ النشر | 2021-05-31 |
اسم المنشور | Pharmacological Research |
المعرّف | http://dx.doi.org/10.1016/j.phrs.2021.105544 |
الاقتباس | Ahmad, E., Ali, A., Fatima, M. T., Kumar, A., Sumi, M. P., Sattar, R. S. A., ... & Saluja, S. S. (2021). Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research, 167, 105544. |
الرقم المعياري الدولي للكتاب | 10436618 |
الملخص | Cancer is one of the major global health problems, responsible for the second-highest number of deaths. The genetic and epigenetic changes in the oncogenes or tumor suppressor genes alter the regulatory pathways leading to its onset and progression. Conventional methods are used in appropriate combinations for the treatment. Surgery effectively treats localized tumors; however, it fails to treat metastatic tumors, leading to a spread in other organs, causing a high recurrence rate and death. Among the different strategies, the nanocarriers-based approach is highly sought for, but its nonspecific delivery can cause a profound side effect on healthy cells. Targeted nanomedicine has the advantage of targeting cancer cells specifically by interacting with the receptors overexpressed on their surface, overcoming its non-specificity to target healthy cells. Nanocarriers prepared from biodegradable and biocompatible materials are decorated with different ligands by encapsulating therapeutic or diagnostic agents or both to target cancer cells overexpressing the receptors. Scientists are now utilizing a theranostic approach to simultaneously evaluate nanocarrier bio-distribution and its effect on the treatment regime. Herein, we have summarized the recent 5-year efforts in the development of the ligands decorated biodegradable nanocarriers, as a targeted nanomedicine approach, which has been highly promising in the treatment of cancer. |
اللغة | en |
الناشر | Elsevier |
الموضوع | Hyaluronic Acid Biodegradable nanocarriers Transferrin Phospholipids CD44 |
النوع | Article |
رقم المجلد | 167 |
تحقق من خيارات الوصول
الملفات في هذه التسجيلة
الملفات | الحجم | الصيغة | العرض |
---|---|---|---|
لا توجد ملفات لها صلة بهذه التسجيلة. |
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث الصيدلة [1261 items ]